Color

#714C00

Hero Carousel

Spotlight

What expatriates bring

YouTube

https://www.youtube.com/channel/UCQDMOSbJtqrtNzif5rS22OQ

Slideshare

http://www.slideshare.net/economistintelligenceunit

Pinterest

https://www.pinterest.com/theeiu/

Sanwa Dengyo—The China connection

Masato Yamaji is the second-generation boss of the Sanwa Dengyo Group, a plant engineering business headquartered in Kagawa Prefecture, with 260 employees across the group’s seven companies. Like many firms in Japan, Sanwa is facing the challenge of a mature and shrinking domestic market. The market has declined “by more than half” compared with the boom times before the bursting of the economic bubble. Survival now depends on finding new markets, whether through innovation or going overseas, while finding ways to slash costs.

Cubic—Small hotels, big ambitions

Cubic, a small Tokyo-based capsule hotel business with just eight employees, may not be the stereotypical SME in that it has used lessons learned in turning around its own business to give advice to other struggling hotels. But it is atypical in other ways—including its president’s international ambition and commitment to innovation.

Kamijima Heat Treatment—A tradition of skill

The Kamijima Heat Treatment plant is located in the back streets of Tokyo’s Ota Ward, known as the city of craftsmanship, or monozukuri no machi. Like many SMEs in Japan’s manufacturing supply chain, Kamijima is a niche business built on artisanship, a tradition it carries on today. As well as the modern vacuum furnaces for metal heat treatment, Kamijima’s skilled workforce also use the older salt bath method, a practice that is gradually dying out.

Brazilian "frugal engineering"

Brazilian companies could benefit from a significant competitive advantage in the global market: their mastery of frugal engineering. Cutting costs and increasing access to good-quality healthcare are twin imperatives worldwide. In this environment, the dissemination of cheaper technology is a winning proposition. Despite a lack of resources, many companies have successfully developed equipment that uses simple technologies to achieve the same results as more sophisticated devices.

Making the most of little: India explores new models

India faces many of the same challenges as Brazil and provides an example of an innovative approach to healthcare. The country is leveraging its role as a contract researcher and manufacturer of generic drugs to increase the value of its output, for example by developing branded generic drugs and new formulations for existing drugs. Through “reverse pharmacology” it is developing and launching medications based on its traditional treatments at a fraction of the cost of drugs developed by Western companies—US$50m, compared with US$1bn respectively.

Delinking health from wealth: Business model innovation transforming Indian healthcare

When Devi Shetty was training as a heart surgeon in the 1980s, he was taught that healthcare is expensive. Some day, his tutors told him, everyone would grow rich enough to afford it.

But, as an Indian national living in a country with hundreds of millions of destitute and poor, Dr Shetty realised he couldn’t afford to wait. His countrymen needed health today, at prices they could afford, not in 50 years’ time when India had grown rich.

Collaboration is a two-way street

Before Nokia launched its new 5800 XpressMusic phone in China in the spring of 2009, the Finnish mobile phone giant disclosed the device's specific features to local software developers with which it collaborates. The 5800 would have a touch screen, a motion sensor and plenty of features geared towards young music lovers, including a memory chip that could hold up to 6,000 music tracks. Armed with this information, Simlife, a game developer based in Fujian province, pitched X Dancery, a game that scores players on their ability to tap out a beat to the music from their own music library.

Vaccine development in China: Collaboration helps Sinovac take the lead

Two golden rules for successful collaboration? “Don’t create heroes and make sure everyone has the same goal,” says chief executive officer (CEO) Yin Weidong. His company, Sinovac Biotech, is one of China’s leading producers of vaccines and has been at the front of vaccine research since China’s outbreaks of SARS (severe acute respiratory syndrome) in 2003 and avian flu in 2005.

American Leather: US company on a global journey

 American Leather is a Dallas-based producer of high-end furniture with annual revenue of around US$90m. Bob Duncan, CEO, explains that the company was initially reluctant to test foreign waters largely because “the US market is so substantial that you don’t have to expand [overseas] to have a significant business. There was always enough opportunity and no need to go to the expense and trouble [of working internationally] when in the US you know the market and know the regulations.”

The public v private debate

The term public-private partnership (PPP) covers a multitude of deal structures where a government service is funded or operated, or both, through a partnership between the public sector and private business. It is widely used but still controversial in some settings.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week